No abstract available
MeSH terms
-
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / pharmacology*
-
Animals
-
Antiparkinson Agents / pharmacology*
-
Brain Mapping
-
Carbidopa / pharmacology
-
Corpus Striatum / drug effects
-
Corpus Striatum / physiopathology
-
Dopamine Agents / pharmacology*
-
Dose-Response Relationship, Drug
-
Down-Regulation / drug effects
-
Down-Regulation / physiology
-
Drug Combinations
-
Dyskinesia, Drug-Induced / physiopathology*
-
Female
-
Levodopa / pharmacology
-
Locomotion / drug effects
-
Locomotion / physiology
-
Macaca fascicularis
-
Parkinson Disease, Secondary / chemically induced*
-
Parkinson Disease, Secondary / physiopathology
-
Psychomotor Performance / drug effects
-
Psychomotor Performance / physiology
-
Receptors, Dopamine D1 / drug effects*
-
Receptors, Dopamine D1 / physiology
-
Receptors, Dopamine D2 / drug effects*
-
Receptors, Dopamine D2 / physiology
Substances
-
Antiparkinson Agents
-
Dopamine Agents
-
Drug Combinations
-
Receptors, Dopamine D1
-
Receptors, Dopamine D2
-
carbidopa, levodopa drug combination
-
Levodopa
-
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
-
Carbidopa